Search Results for: ES cell

Biotechnology & the Ethical Imagination – A Preview of BEINGS summit

beings-logo

Later this May, I will attend and participate in Biotechnology and the Ethical Imagination (BEINGS 2015). This is an exciting and experimental summit that will focus on advances in cellular biotechnology – including both stem cell science and synthetic biology. The meeting is premised on the idea that the implications of increasing biotechnology power are […]

Biotechnology & the Ethical Imagination – A Preview of BEINGS summit Read More »

4 areas of debate on 1st human embryo genetic modification paper

human-genetic-modification

Last week was a big one for the life sciences in that we saw the milestone of the first ever published paper reporting human embryo genetic modification (see here and here). It was one of those situations where we knew it was coming, but it was still a jolt. Not surprisingly this event sparked intense discussion

4 areas of debate on 1st human embryo genetic modification paper Read More »

The big blind spot on CRISPR for human embryo editing: PGD

blind-spot

There is a big old blind spot in the discussion over germline gene editing in humans: preimplantation genetic diagnosis (PGD). There’s been a lot of talk in 2015 about worries over how gene editing technology such as CRISPR might be used prematurely in the clinic in an unsafe or unethical manner in humans in the

The big blind spot on CRISPR for human embryo editing: PGD Read More »

Interview with Bioheart CSO, Kristin Comella including on FDA

Kristin-Comella1

I invited the Chief Scientific Officer (CSO) of Bioheart, Kristin Comella, to do an interview after hearing some buzz that this could be a critical time for the company and that it might have been recently visited by the FDA. Note that Comella not just Bioheart CSO, but also the primary instructor for physician training in stem

Interview with Bioheart CSO, Kristin Comella including on FDA Read More »

Hank Greely Human Germline Modification Post

Week-8-Cover

Hank Greely over at The Center for Law and Biosciences at Stanford Law School was one of the participants in the recent Napa meeting on approaches to human germline genetic modification. Hank was also one of the authors on the resulting position paper in Science with David Baltimore as first author (here). Now Hank, pictured below,

Hank Greely Human Germline Modification Post Read More »